Article Information
History
- August 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chemtai Mungo1,2,3,*,
- Konyin Adewumi4,
- Mercy Rop5,6,
- Antony Owaya5,
- Everlyn Adoyo5,
- Aparna Ghosh Kachoria7,
- Jennifer H Tang1,2 and
- Lisa Rahangdale1,2,3
- 1Department of Obstetrics and Gynecology, University of North Carolina-Chapel Hill, Chapel Hill, USA
- 2Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel Hill, USA
- 3Center for AIDS Research, University of North Carolina-Chapel Hill, Chapel Hill, USA
- 4Duke University School of Medicine, Durham NC, USA
- 5Center for Microbiology Research, Kenya Medical Research Institute, Kisumu, Kenya
- 6Division of Epidemiology and Biostatistics, Stellenbosch University, Cape Town, South Africa
- 7Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina – Chapel Hill, USA
- ↵*Corresponding author: Chemtai Mungo 3009 Old Clinic Building, CB #7570, Chapel Hill, North Carolina 27599 chemtai_mungo{at}med.unc.edu
Posted August 28, 2024.
Women’s experiences and acceptability of self-administered, home delivered, intravaginal 5-Fluorouracil cream for cervical precancer treatment in Kenya
